Validation of a glucose-insulin-potassium infusion algorithm in hospitalized diabetic patients

Journal of Internal Medicine

Volumn 253, Issue 2, 2003, Pages 189-193

  Bonnier, Mats ^a   Lonnroth P ^a   Gudbjornsdottir S ^a   Attvall, S ^a   Jansson, P A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes complications; Diabetes mellitus; Glucose insulin infusion; Metabolic control

Indexed keywords

GLUCOSE; INSULIN; NEUTRAL INSULIN; POTASSIUM;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INFUSION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DEPARTMENT; HUMAN; HYPOGLYCEMIA; INTERMETHOD COMPARISON; MALE; METABOLIC REGULATION; NURSING STAFF; PRIORITY JOURNAL; PROGNOSIS; UNIVERSITY HOSPITAL; VALIDATION PROCESS;

AGED; ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; POTASSIUM;

EID: 0037322441     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01085.x     Document Type: Article

References (24)

1. Sodi-Pallares D, Testelli MR, Fischleder BL. Effects of an intravenous infusion of a potassium glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962; 9: 166-81.
2. Van den Berghe G, Wouters P, Weekwers F. et al. Intensive insulin in critically ill patients. N Engl J Med 2001; 19: 1359-67.
3. Malmberg K, Efendic S, Rydén L. Feasability of insulin-glucose infusion in diabetic patients with acute myocardial infarction. Diabetes Care 1994; 17: 1007-14.
4. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effect on mortality at 1 year. JACC 1995; 26: 57-65.
5. Malmberg K, for the DIGAMI. Prospective randomized study of intensive insulin treatment on long survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 512-5.
6. Wier CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 1997; 314: 1303-6.
7. Gwilt D, Nattrass M, Pentecost B. Use of low-dose insulin infusion in diabetics after myocardial infarction. BMJ 1982; 285: 1402-4.
8. Alberti KGMM, Gill GV, Elliott MJ. Insulin delivery during surgery in the diabetic patient. Diabetes Care Suppl 1982; 1: 65-76.
9. Christiansen CL, Schurizek BA, Malling B, Knudsen L, Alberti KGMM, Hermansen K. Insulin treatment of the insulin-dependent patient undergoing minor surgery. Anaesthesia 1988; 43: 533-7.
10. Hendra TJ, Yudkin JS. An algorithm for tight glycaemic control in diabetic infarct survivors. Diabetes Res Clin Pract 1992; 16: 213-20.
11. Furnary AP, Zerr KJ, Grunkmeier GL, Starr A. Continuous insulin infusion reduces the incidens of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Am Thorac Surg 1995; 67: 352-63.
12. Kjellman UW, Dahlin A, Ekroth R, Kirnö K, Svensson G, Wernerman J. Insulin (GIK) improves myocardial metabolism in patients during blood Cardioplegia. Scand Cardiovasc J 2000; 34: 321-30.
13. Svedjeholm R, Håkansson E, Szabo Z. Optimal dosage of insulin and glucose in glucose-insulin-potassium treatment of acute myocardial infarcion remains to be established. Circulation 1999; 100: e106.
14. Ashworth L, Alberti KGMM. Hemocue: evaluation of a portable photometric system for determining glucose vein whole blood. Clin Chem 1992; 38: 1479-82.
15. Rassias AJ, Marrin CA, Arruda J, Whaler PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999; 88: 1011-6.
16. Zerr JK, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Start A. Glucose control lowers the risk of wound infection in diabetes after open heart Operation. Am Thorac Surg 1997; 63: 356-61.
17. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulins. J Trauma 1990; 30: 830-3.
18. Hostetter M. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990; 39: 271-5.
19. Bagdade JD, Root RK, Bulger RJ. Impaired leucocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 9-15.
20. Sima AAF, O'Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes 1988; 37: 544-9.
21. Mowat AG, Baum J. Chemotaxis of polymorphonuclear leucocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621.
22. Hill Golden S, Peart-Vigilance C, Kao WHL, Brancanti FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22: 1408-14.
23. Yki-Järvinen H. Toxicity of hyperglycaemia in type 2 diabetes. Diabetes. Metab Rev 1998; Suppl 1: 45-50.
24. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D. Influence of diabetes mellitus and glycemic control on the characteristics and outcome of common infections. Diabet Med 1996; 13: 457-63.